These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8440603)

  • 21. Better response to s.c. erythropoietin in CAPD than HD patients.
    Stegmayr BG
    Scand J Urol Nephrol; 1997 Apr; 31(2):183-7. PubMed ID: 9165584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dialysis efficiency in continuous ambulatory peritoneal dialysis patients treated with erythropoietin.
    Taylor JE; MacTier RA; Henderson IS; Belch JJ; Stewart WK
    Perit Dial Int; 1992; 12(2):221-6. PubMed ID: 1586685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human erythropoietin therapy in haemodialysis patients--dose determination and clinical experience.
    Bommer J; Alexiou C; Müller-Bühl U; Eifert J; Ritz E
    Nephrol Dial Transplant; 1987; 2(4):238-42. PubMed ID: 3118264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human erythropoietin therapy in children maintained by haemodialysis.
    Rigden SP; Montini G; Morris M; Clark KG; Haycock GB; Chantler C; Hill RC
    Pediatr Nephrol; 1990 Nov; 4(6):618-22. PubMed ID: 2088464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT; Prata MM; Barbas JV; dos Santos JP
    Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P; Andre JL; Treize G; Leroy B
    Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A; Paoletti E; Molinelli G
    Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.
    Goicoechea M; Vazquez MI; Ruiz MA; Gomez-Campdera F; Perez-García R; Valderrábano F
    Nephron; 1998; 78(1):23-7. PubMed ID: 9453399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
    Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
    Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients.
    Sitter T; Bergner A; Schiffl H
    Nephrol Dial Transplant; 2000 Aug; 15(8):1207-11. PubMed ID: 10910446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M; Boguszewska-Baczkowska A; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Utilization of EPO in CAPD].
    Ramello A; Perosa P; Bruno M; Reina E; Rizzuto A; Bertasso L; Roggero A; Malcangi U
    Minerva Urol Nefrol; 1991; 43(3):137-41. PubMed ID: 1817335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma concentrations of immunoreactive-endothelin in patients with chronic renal failure treated with recombinant human erythropoietin.
    Takahashi K; Totsune K; Imai Y; Sone M; Nozuki M; Murakami O; Sekino H; Mouri T
    Clin Sci (Lond); 1993 Jan; 84(1):47-50. PubMed ID: 8382133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
    Branger B; Vécina F; Zabadani B; Balducchi JP; Fourcade J
    Nephrol Dial Transplant; 1995; 10 Suppl 6():36-9. PubMed ID: 8524492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional variability in anaemia management and haemoglobin in the US.
    Reddan DN; Frankenfield DL; Klassen PS; Coladonato JA; Szczech L; Johnson CA; Besarab A; Rocco M; McClellan W; Wish J; Owen WF;
    Nephrol Dial Transplant; 2003 Jan; 18(1):147-52. PubMed ID: 12480973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment.
    Hughes RT; Cotes PM; Pippard MJ; Stevens JM; Oliver DO; Winearls CG; Royston JP
    Br J Haematol; 1990 Jun; 75(2):268-73. PubMed ID: 2372513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human recombinant erythropoietin in anaemic patients on maintenance haemodialysis. Secondary effects of the increase of haemoglobin.
    Zehnder C; Glück Z; Descoeudres C; Uehlinger DE; Blumberg A
    Nephrol Dial Transplant; 1988; 3(5):657-60. PubMed ID: 3146724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of renal anaemia in CAPD patients with recombinant human erythropoietin.
    Macdougall IC; Davies ME; Hutton RD; Cavill I; Lewis NP; Coles GA; Williams JD
    Nephrol Dial Transplant; 1990; 5(11):950-5. PubMed ID: 2127832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluctuations in haemoglobin levels in haemodialysis, pre-dialysis and peritoneal dialysis patients receiving epoetin alpha or darbepoetin alpha.
    Walker R; Pussell BA;
    Nephrology (Carlton); 2009 Oct; 14(7):689-95. PubMed ID: 19796029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.